[Elsevier] Targeting the PERK/NRF2 pathway: Enhancing cisplatin efficacy in resistant ovarian cancer cells via MRP1 and ROS modulation

thebigmori Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-28 02:54
Reward20points

journalㄩFood and Chemical Toxicology

AuthorsㄩSeyedeh Sara Ghorbanhosseini; Mitra Nourbakhsh; Fatemeh Mosaffa; Mahmoud Aghaei

Published dateㄩ2025-10-

DOIㄩ10.1016/j.fct.2025.115672

PDF linkㄩhttps://www.sciencedirect.com/sc ... 278691525004405/pdf

Article linkㄩhttps://doi.org/10.1016/j.fct.2025.115672

Article SourceㄩElsevier BV


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list